These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19595600)

  • 21. Edaravone derivatives containing NO-donor functions.
    Chegaev K; Cena C; Giorgis M; Rolando B; Tosco P; Bertinaria M; Fruttero R; Carrupt PA; Gasco A
    J Med Chem; 2009 Jan; 52(2):574-8. PubMed ID: 19113954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synthesis and vascular relaxing activity of arecoline derivatives coupled with nitric oxide donors].
    Huang ST; Huang WL; Zhang HB
    Yao Xue Xue Bao; 2006 Jan; 41(1):71-5. PubMed ID: 16683531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antioxidant status in experimental type 2 diabetes mellitus: effects of glibenclamide and glipizide on various rat tissues.
    Tüzün S; Girgin FK; Sözmen EY; Menteş G; Ersöz B
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):436-41. PubMed ID: 10445412
    [No Abstract]   [Full Text] [Related]  

  • 24. Structure-activity relationships of spontaneous nitric oxide releasers, FK409 and its derivatives.
    Fukuyama S; Hirasawa Y; Kato Y; Nishio M; Ohno M; Nishino S; Maeda K; Kato M; Kita Y
    J Pharmacol Exp Ther; 1997 Jul; 282(1):236-42. PubMed ID: 9223559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential protective properties of a stable, slow-releasing nitric oxide donor, GEA 3175, in the lung.
    Laursen BE; Stankevicius E; Pilegaard H; Mulvany M; Simonsen U
    Cardiovasc Drug Rev; 2006; 24(3-4):247-60. PubMed ID: 17214601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and evaluation of phenylfuroxan nitric oxide-donor phenols as potential anti-diabetic agents.
    Xie YD; Shao LH; Wang QT; Bai Y; Li N; Yang G; Li YP; Bian XL
    Bioorg Chem; 2019 Aug; 89():103000. PubMed ID: 31132604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin.
    Wang C; Li J; Lv X; Zhang M; Song Y; Chen L; Liu Y
    Eur J Pharmacol; 2009 Oct; 620(1-3):131-7. PubMed ID: 19686728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues.
    Tamboli Y; Lazzarato L; Marini E; Guglielmo S; Novelli M; Beffy P; Masiello P; Fruttero R; Gasco A
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3810-5. PubMed ID: 22565215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diazen-1-ium-1,2-diolated and nitrooxyethyl nitric oxide donor ester prodrugs of anti-inflammatory (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic acids: synthesis, cyclooxygenase inhibition, and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Chen QH; Knaus EE
    Bioorg Med Chem; 2008 Mar; 16(6):3302-8. PubMed ID: 18096394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New 1,4-dihydropyridines endowed with NO-donor and calcium channel agonist properties.
    Visentin S; Rolando B; Di Stilo A; Fruttero R; Novara M; Carbone E; Roussel C; Vanthuyne N; Gasco A
    J Med Chem; 2004 May; 47(10):2688-93. PubMed ID: 15115410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do nitric oxide-releasing drugs offer a potentially new paradigm for the management of cardiovascular risks in diabetes?
    Bhardwaj A; Kaur J; Wuest F; Knaus EE
    Expert Rev Cardiovasc Ther; 2014 May; 12(5):533-6. PubMed ID: 24725228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can nitric oxide-releasing hybrid drugs alleviate adverse cardiovascular risks?
    Bhardwaj A; Kaur J; Knaus EE
    Future Med Chem; 2013 Mar; 5(4):381-3. PubMed ID: 23495685
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet dysfunction associated with insulin therapy in patients with type 2 diabetes: please do not throw the baby out with the bathwater!
    Scheen AJ; Legrand D
    J Am Coll Cardiol; 2007 Feb; 49(5):628; author reply 628-9. PubMed ID: 17276192
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin.
    Cena C; Lolli ML; Lazzarato L; Guaita E; Morini G; Coruzzi G; McElroy SP; Megson IL; Fruttero R; Gasco A
    J Med Chem; 2003 Feb; 46(5):747-54. PubMed ID: 12593655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Velázquez C; Das D; Suresh MR; Knaus EE
    Bioorg Med Chem; 2008 Nov; 16(22):9694-8. PubMed ID: 18930406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes.
    Räkel A; Renier G; Roussin A; Buithieu J; Mamputu JC; Serri O
    Diabetes Obes Metab; 2007 Jan; 9(1):127-9. PubMed ID: 17199728
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of novel agents based on nitric oxide for the control of colon cancer.
    Kozoni V; Rosenberg T; Rigas B
    Acta Pharmacol Sin; 2007 Sep; 28(9):1429-33. PubMed ID: 17723176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic role of nitric oxide as emerging molecule.
    Kumar S; Singh RK; Bhardwaj TR
    Biomed Pharmacother; 2017 Jan; 85():182-201. PubMed ID: 27940398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 1-(4-methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids: synthesis, nitric oxide release studies and anti-inflammatory activities.
    Abdellatif KR; Chowdhury MA; Dong Y; Knaus EE
    Bioorg Med Chem; 2008 Jul; 16(13):6528-34. PubMed ID: 18513975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antidiabetes drug metformin is a donor of nitric oxide: ESR measurement of efficiency].
    Serezhenkov VA; Kuznetsov IS; Romantsova TI; Kuznetsova MI; Vanin AF
    Biofizika; 2011; 56(6):1125-33. PubMed ID: 22279758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.